Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Administrative data

Endpoint:
acute toxicity: oral
Type of information:
experimental study
Adequacy of study:
key study
Study period:
February 2015 to April 2015
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2015
Report date:
2015

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to guideline
Guideline:
OECD Guideline 420 (Acute Oral Toxicity - Fixed Dose Method)
Qualifier:
according to guideline
Guideline:
EPA OPPTS 870.1100 (Acute Oral Toxicity)
GLP compliance:
yes (incl. QA statement)
Test type:
fixed dose procedure
Limit test:
yes

Test material

Constituent 1
Chemical structure
Reference substance name:
3-[2-methyl-4-(2-methylpropyl)phenyl]propanal
EC Number:
811-285-3
Cas Number:
1637294-12-2
Molecular formula:
C14H20O
IUPAC Name:
3-[2-methyl-4-(2-methylpropyl)phenyl]propanal
Test material form:
liquid
Specific details on test material used for the study:
Name (as stated in the report): GR-88-0778
Lot No: Batch 6
Aspect: Colourless liquid
Expiration date: March 29, 2017

Test animals

Species:
rat
Strain:
Wistar
Remarks:
Crl:WI (outbred, SPF-Quality)
Sex:
female
Details on test animals or test system and environmental conditions:
- Source: Charles River Deutschland, Sulzfeld, Germany
- Number of animals: Pilot Study: 1 female, Main Study: 4 females (females were nulliparous and non-pregnant).
- Age and body weight: Young adult animals (approx. 8-9 weeks old) were selected. Body weight variation did not exceed +/- 20% of the sex mean.
- Identification: Earmark
- Health inspection: 4At least prior to dosing. It is ensured that the animals were healthy and without any abnormality that might affect the study integrity

Administration / exposure

Route of administration:
oral: gavage
Vehicle:
unchanged (no vehicle)
Details on oral exposure:
- Method: Oral gavage, using plastic feeding tubes. The test substance was stirred on a magnetic stirrer during dosing.
Doses:
2000 mg/kg bw
No. of animals per sex per dose:
a group of 4 females (females were nulliparous and non-pregnant) / 1 dose per group
Control animals:
no
Details on study design:
Initially, GR-88-0778 was administered by oral gavage to one female Wistar rat at 2000 mg/kg body weight. As no mortality occurred and no signs of significant toxicity were observed, the main study was conducted with a fixed dose of 2000 mg/kg body weight administered to four female rats. The animals were subjected to daily observations. Body weights were determined on Days 1, 8 and 15.
Macroscopic examination was performed after terminal sacrifice.

Results and discussion

Effect levels
Key result
Sex:
female
Dose descriptor:
LD50
Effect level:
> 2 000 mg/kg bw
Based on:
test mat.
Mortality:
No mortality occurred.
Clinical signs:
other: Hunched posture, uncoordinated movements and/or piloerection were noted for the animals on Day 1.
Gross pathology:
No abnormalities were found at macroscopic post mortem examination of the animals

Applicant's summary and conclusion

Interpretation of results:
not classified
Conclusions:
The minimum oral lethal dose of GR-88-0778 in rats was established to exceed 2000 mg/kg body weight.
Executive summary:

The acute oral toxicity with GR-88-0778 was assessed in the rat (Fixed Dose Method) according to the OECD No.420 (2001) " Acute toxicity-oral, Fixed Dose Procedure".

Initially, GR-88-0778 was administered by oral gavage to one female Wistar rat at 2000 mg/kg body weight. As no mortality occurred and no signs of significant toxicity were observed, the main study was conducted with a fixed dose of 2000 mg/kg body weight administered to four female rats. The animals were subjected to daily observations. Body weights were determined on Days 1, 8 and 15. Macroscopic examination was performed after terminal sacrifice.

No mortality occurred.

Hunched posture, uncoordinated movements and/or piloerection were noted for the animals on Day 1.

The body weight gain shown by the animals over the study period was considered to be normal.

No abnormalities were found at macroscopic post mortem examination of the animals.

The minimum oral lethal dose of GR-88-0778 in rats was established to exceed 2000 mg/kg body weight.